History of RXMD Dilution Machine..
History of RXMD Dilution thru Jun-2016..
Issued to Original S/H………………………2,280,000…… 2007
Issued for Debt………………………………3,000,000……2008-2009
Issued for PharmCo Acquisition………….30,000,000……2010-2010
Issued for Services……………………….……302,261……2010-2011
Issued for Services-Armen…………….……1,385,596……2010-2011
Issued for Debt………………………….……1,098,973……2010-2011
Restated Original S/H Issue………….……-1,718,000……2010-2011
Issued for Debt………………………….……..196,078……2011-2012
Issued for Services…………………….……….60,000……2011-2012
Issued for Services-Armen………….………..424,983……2011-2012
Retired PharmCo Issue……………….….-12,208,432……2011-2012
Issued for Debt………………………………2,500,000……2012-2013
Issued for Services……………………….……234,885……2012-2013
Issued for Services-Armen…………………...150,000……2012-2013
Issued for Services-Armen…………………5,000,000……2013-2014
Issued for Debt-3(a)(10) ……………………8,362,000……2013-2014
Issued for Debt-3(a)(10)…………………273,913,000……2014-2015
Issued for Services………………………...20,000,000……2014-2015
Issued for Debt………………………………6,083,985……2014-2015
Issued for Bonuses………………………..10,977,716……2014-2015
Retired Debt Issuance-3(a)(10)…………-12,497,838……2015-2016
Issued for Services………………………….1,562,500……May-2016
Total……………………………………….341,107,607
Issued Share Summary thru Jun-2016:
Issued to Original S/H…………………………562,000
Issued for PharmCo Acquisition………….17,791,568
Issued for Services-Armen…………………6,960,579
Issued for Other Services…………………22,159,646
Issued for Bonuses…………………….…..10,977,716
Issued for Debt…………………………...282,656,198
Total…………………………………….…341,107,607
Subsequent Contracts/Remaining Dilution Since Jun-2016..
08/22/2016: MBS Due Diligence Fee-Fully Vested Shs….500,000
02/22/2017: MBS Due Diligence Fee-Balance Shs..........500,000
04/06/2016: Mass Ventures.....Remaining Shs valued at......$ 17,500
07/22/2016: Chicago Ventures...Remaining Shs valued at...$2,205,000
Since RXMD only has 500M shares authorized, expect to see this increased then followed by a reverse split of the corporate shares..
